Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Confluent (CFLT) Cash & Equivalents: 2020-2025

Historic Cash & Equivalents for Confluent (CFLT) over the last 6 years, with Sep 2025 value amounting to $298.5 million.

  • Confluent's Cash & Equivalents fell 7.46% to $298.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $298.5 million, marking a year-over-year decrease of 7.46%. This contributed to the annual value of $386.0 million for FY2024, which is 10.36% up from last year.
  • As of Q3 2025, Confluent's Cash & Equivalents stood at $298.5 million, which was up 1.00% from $295.6 million recorded in Q2 2025.
  • Confluent's 5-year Cash & Equivalents high stood at $1.4 billion for Q4 2021, and its period low was $44.1 million during Q1 2021.
  • In the last 3 years, Confluent's Cash & Equivalents had a median value of $317.0 million in 2023 and averaged $322.9 million.
  • Per our database at Business Quant, Confluent's Cash & Equivalents surged by 3,640.06% in 2021 and then tumbled by 68.33% in 2022.
  • Over the past 5 years, Confluent's Cash & Equivalents (Quarterly) stood at $1.4 billion in 2021, then tumbled by 68.33% to $435.8 million in 2022, then declined by 19.74% to $349.8 million in 2023, then increased by 10.36% to $386.0 million in 2024, then decreased by 7.46% to $298.5 million in 2025.
  • Its Cash & Equivalents stands at $298.5 million for Q3 2025, versus $295.6 million for Q2 2025 and $278.6 million for Q1 2025.